These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

261 related items for PubMed ID: 15332389

  • 1. Montelukast protects against nasal lysine-aspirin challenge in patients with aspirin-induced asthma.
    Lee DK, Haggart K, Robb FM, Lipworth BJ.
    Eur Respir J; 2004 Aug; 24(2):226-30. PubMed ID: 15332389
    [Abstract] [Full Text] [Related]

  • 2. Reproducibility of response to nasal lysine-aspirin challenge in patients with aspirin-induced asthma.
    Lee DK, Haggart K, Lipworth BJ.
    Ann Allergy Asthma Immunol; 2004 Aug; 93(2):185-8. PubMed ID: 15328680
    [Abstract] [Full Text] [Related]

  • 3. Protection against exercise-induced bronchoconstriction by montelukast in aspirin-sensitive and aspirin-tolerant patients with asthma.
    Mastalerz L, Gawlewicz-Mroczka A, Nizankowska E, Cmiel A, Szczeklik A.
    Clin Exp Allergy; 2002 Sep; 32(9):1360-5. PubMed ID: 12220476
    [Abstract] [Full Text] [Related]

  • 4. Montelukast 10 mg improves nasal function and nasal response to aspirin in ASA-sensitive asthmatics: a controlled study vs placebo.
    Micheletto C, Tognella S, Visconti M, Pomari C, Trevisan F, Dal Negro RW.
    Allergy; 2004 Mar; 59(3):289-94. PubMed ID: 14982510
    [Abstract] [Full Text] [Related]

  • 5. Effects of single or combined histamine H1-receptor and leukotriene CysLT1-receptor antagonism on nasal adenosine monophosphate challenge in persistent allergic rhinitis.
    Lee DK, Jackson CM, Soutar PC, Fardon TC, Lipworth BJ.
    Br J Clin Pharmacol; 2004 Jun; 57(6):714-9. PubMed ID: 15151516
    [Abstract] [Full Text] [Related]

  • 6. Urinary LTE4 is higher after nasal provocation test with L-ASA in bronchial than in only nasal responders.
    Micheletto C, Visconti M, Tognella S, Trevisan F, Dal Negro RW.
    Eur Ann Allergy Clin Immunol; 2007 May; 39(5):162-6. PubMed ID: 17626331
    [Abstract] [Full Text] [Related]

  • 7. Nasal provocation test with lysine-aspirin for diagnosis of aspirin-sensitive asthma.
    Milewski M, Mastalerz L, Nizankowska E, Szczeklik A.
    J Allergy Clin Immunol; 1998 May; 101(5):581-6. PubMed ID: 9600492
    [Abstract] [Full Text] [Related]

  • 8. Montelukast, a potent leukotriene receptor antagonist, causes dose-related improvements in chronic asthma. Montelukast Asthma Study Group.
    Noonan MJ, Chervinsky P, Brandon M, Zhang J, Kundu S, McBurney J, Reiss TF.
    Eur Respir J; 1998 Jun; 11(6):1232-9. PubMed ID: 9657560
    [Abstract] [Full Text] [Related]

  • 9. The leukotriene-receptor antagonist MK-0679 blocks airway obstruction induced by inhaled lysine-aspirin in aspirin-sensitive asthmatics.
    Dahlén B, Kumlin M, Margolskee DJ, Larsson C, Blomqvist H, Williams VC, Zetterström O, Dahlén SE.
    Eur Respir J; 1993 Jul; 6(7):1018-26. PubMed ID: 8396534
    [Abstract] [Full Text] [Related]

  • 10. An open audit of montelukast, a leukotriene receptor antagonist, in nasal polyposis associated with asthma.
    Ragab S, Parikh A, Darby YC, Scadding GK.
    Clin Exp Allergy; 2001 Sep; 31(9):1385-91. PubMed ID: 11591188
    [Abstract] [Full Text] [Related]

  • 11. Improvement of aspirin-intolerant asthma by montelukast, a leukotriene antagonist: a randomized, double-blind, placebo-controlled trial.
    Dahlén SE, Malmström K, Nizankowska E, Dahlén B, Kuna P, Kowalski M, Lumry WR, Picado C, Stevenson DD, Bousquet J, Pauwels R, Holgate ST, Shahane A, Zhang J, Reiss TF, Szczeklik A.
    Am J Respir Crit Care Med; 2002 Jan 01; 165(1):9-14. PubMed ID: 11779723
    [Abstract] [Full Text] [Related]

  • 12. Intranasal lysine-aspirin administration decreases polyp volume in patients with aspirin-intolerant asthma.
    Ogata N, Darby Y, Scadding G.
    J Laryngol Otol; 2007 Dec 01; 121(12):1156-60. PubMed ID: 17697437
    [Abstract] [Full Text] [Related]

  • 13. Inhaled PGE2 prevents aspirin-induced bronchoconstriction and urinary LTE4 excretion in aspirin-sensitive asthma.
    Sestini P, Armetti L, Gambaro G, Pieroni MG, Refini RM, Sala A, Vaghi A, Folco GC, Bianco S, Robuschi M.
    Am J Respir Crit Care Med; 1996 Feb 01; 153(2):572-5. PubMed ID: 8564100
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Is a positive nasal lysine-aspirin challenge test associated with a more severe phenotype of chronic rhinosinusitis and asthma?
    Vaidyanathan S, Williamson PA, Lipworth BJ.
    Am J Rhinol Allergy; 2012 Feb 01; 26(3):e89-93. PubMed ID: 22643934
    [Abstract] [Full Text] [Related]

  • 18. Changes in urinary LTE4 and nasal functions following nasal provocation test with ASA in ASA-tolerant and -intolerant asthmatics.
    Micheletto C, Tognella S, Visconti M, Trevisan F, Dal Negro RW.
    Respir Med; 2006 Dec 01; 100(12):2144-50. PubMed ID: 16678396
    [Abstract] [Full Text] [Related]

  • 19. Distribution of therapeutic response in asthma control between oral montelukast and inhaled beclomethasone.
    Baumgartner RA, Martinez G, Edelman JM, Rodriguez Gomez GG, Bernstein M, Bird S, Angner R, Polis A, Dass SB, Lu S, Reiss TF, Montelukast Asthma Study Group.
    Eur Respir J; 2003 Jan 01; 21(1):123-8. PubMed ID: 12570120
    [Abstract] [Full Text] [Related]

  • 20. Comparative effects of desloratadine, fexofenadine, and levocetirizine on nasal adenosine monophosphate challenge in patients with perennial allergic rhinitis.
    Lee DK, Gardiner M, Haggart K, Fujihara S, Lipworth BJ.
    Clin Exp Allergy; 2004 Apr 01; 34(4):650-3. PubMed ID: 15080821
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.